(2S,16S,17S,18R,19R,20R,21S,22R,23S,24E)-9-[2-(1-butyl-2,2-dipropylhydrazino)-2-oxoethoxy]-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate (38123-26-1)

Identification
Name:	(2S,16S,17S,18R,19R,20R,21S,22R,23S,24E)-9-[2-(1-butyl-2,2-dipropylhydrazino)-2-oxoethoxy]-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
Synonyms:	Rifamycin B butyldipropylhydrazide;BRN 5418895;38123-26-1;Acetic acid, ((1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-9-yl)oxy)-, 21-acetate, 1-butyl-2,2-dipropylhydrazide;LS-11759;Rifamycin B, 1-butyl-2,2-dipropylhydrazide;Rifamycin, 4-O-[2-(1-butyl-2,2-dipropylhydrazino)-2-oxoethyl]-
CAS:	38123-26-1
Molecular Formula:	C₄₉H₇₁N₃O₁₃
Molecular Weight:	910.1003
InChI:	InChI=1/C49H71N3O13/c1-13-16-23-52(51(21-14-2)22-15-3)37(54)26-62-36-25-34-44(58)39-38(36)40-46(32(9)43(39)57)65-49(11,47(40)59)63-24-20-35(61-12)29(6)45(64-33(10)53)31(8)42(56)30(7)41(55)27(4)18-17-19-28(5)48(60)50-34/h17-20,24-25,27,29-31,35,41-42,45,55-58H,13-16,21-23,26H2,1-12H3,(H,50,60)/b18-17+,24-20+,28-19+/t27-,29+,30+,31+,35-,41-,42+,45+,49-/m0/s1
Molecular Structure:
Properties
Flash Point:	°C
Boiling Point:	°Cat760mmHg
Density:	1.25g/cm³
Refractive index:	1.597
Flash Point:	°C
Safety Data